Sign In
Buy ABBV
$224.93
+7.86 (+3.62%)
At Close: Jun 04, 2026
How Will AbbVie's Neuroscience Franchise Perform in Q2 Earnings?
10:35am, Tuesday, 22'nd Jul 2025
ABBV's neuroscience sales are projected to jump 15% in Q2, driven by Botox Therapeutic, Vraylar and oral migraine drug gains.
Best Dividend Kings: July 2025
09:31am, Tuesday, 22'nd Jul 2025
14 Dividend Kings continue to outperform the S&P 500 in 2025. Dividend growth remains healthy, with one recent increase and a collective 2025 growth rate of 5.23%. Seventeen Dividend Kings currently a
BOTOX® Cosmetic (onabotulinumtoxinA) Selects This Year's Entrepreneurs for The Confidence Project
08:00am, Tuesday, 22'nd Jul 2025
Select Business Owners Will Receive Access to Coaching, Mentorship, and Community During Exclusive 12-Week Virtual "Boostcamp" Additionally, 20 Entrepreneurs Will Each Receive a $20,000 Grant from BOT
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
07:46am, Monday, 21'st Jul 2025
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high
All It Takes Is $2,000 Invested in Each of These High Dividend Stocks to Help Generate Over $280 in Passive Income Per Year
06:15am, Saturday, 19'th Jul 2025
It has been a volatile year for the U.S. markets, with many stocks experiencing impressive highs and sharp lows. Investing in such a turbulent environment may feel daunting for retail investors.
July's 5 Dividend Growth Stocks With Yields Up To 7.96%
02:46pm, Friday, 18'th Jul 2025
Dividend growth stocks can offer a stable way to passively grow one's income, creating long-term compounding wealth over the long run. Today, we are looking at a screening process that focuses on high
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
10:01am, Friday, 18'th Jul 2025
AbbVie (ABBV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Why AbbVie Is a Strong Buy for Long-Term Investors in 2025
05:13am, Friday, 18'th Jul 2025
AbbVie Inc. (ABBV) has emerged as a strong performer in financial and technical terms, attracting investor attention due to its long-term growth potential. With consistent revenue generation and expan
AbbVie (ABBV) Surpasses Market Returns: Some Facts Worth Knowing
06:46pm, Wednesday, 16'th Jul 2025
The latest trading day saw AbbVie (ABBV) settling at $190.58, representing a +2.25% change from its previous close.
How Will AbbVie's Oncology Drugs Aid Upcoming Q2 Results?
09:41am, Wednesday, 16'th Jul 2025
ABBV's oncology sales might have dipped in Q2 as gains from newer drugs face pressure from Imbruvica's ongoing decline.
Here's How to Play AbbVie Stock as it Reaches Golden Cross
09:36am, Tuesday, 15'th Jul 2025
ABBV hits a bullish golden cross as Skyrizi and Rinvoq drive growth, offsetting Humira losses and aesthetic headwinds.
3 No-Brainer Dividend Stocks to Buy In July
07:09am, Saturday, 12'th Jul 2025
There's really no such thing as a “no brainer” stock pick. I'd say that some opportunities are more compelling than others.
3 Dividend Growth Stocks to Buy and Hold
06:40am, Saturday, 12'th Jul 2025
What's better than a great dividend? A great dividend that's growing.
The Smartest Dividend Stocks to Buy With $300 Right Now
05:15am, Saturday, 12'th Jul 2025
Are dividend stocks only for investors nearing or in retirement? Not at all.
ABBV or BMY: Which Biopharma Giant Has Better Prospects for Now?
11:00am, Friday, 11'th Jul 2025
AbbVie edges ahead of Bristol Myers with strong Skyrizi and Rinvoq growth, offsetting Humira declines and portfolio headwinds.
